Global management of total hip and total knee arthroplasty patient populations: a new, comprehensive approach to deep vein thrombosis prophylaxis.
Venous thromboembolic disease remains a common and potentially fatal complication after total joint arthroplasty. The incidence of deep vein thrombosis (DVT) has been reported to be between 5% and 60% in a number of studies using a variety of prophylaxis regimens. Symptomatic pulmonary embolism has been documented as high as 23%, while fatal pulmonary embolism, although relatively infrequent, remains one of the most catastrophic complications of total joint arthroplasty.
Adult Joint Reconstruction Fellow, Department of Orthopaedic Surgery, The Hospital for Special Surgery, Cornell University Medical College, New York, NY.
A
A
Miric
P
P
Lombardi
T P
TP
Sculco